While thousands of cryptocurrencies are now in circulation, only a handful are worthy of investment, in my opinion. The best one to buy with
Two St. Louis wealth management firms merge to form $500M advisory business
Two St. Louis County-based financial planning firms are merging to form a half-billion-dollar wealth advisory business.
Asia’s super-rich families risk losing fortunes without a cohesive wealth transfer plan: Report
Asia Pacific’s richest families risk losing fortunes without cohesive wealth transfer and legacy plans, despite growing interest in AI for growth. Read more at
Stock Market LIVE Updates: GIFT Nifty hints flat start; Asian markets mixed; RBI MPC meet in focus
Asian markets traded mixed on Wednesday morning amid a lack of major triggers. Mainland China’s CSI 300 was down 0.29 per cent, Hong Kong’s
Stock market today: Trade guide for Nifty 50, gold, silver rates to USD vs INR; eight stocks to buy or sell on Wednesday
Experts have recommended eight stocks to buy today — Ashok Leyland, SBI, Paytm, Hindustan Petroleum, UPL, Maruti Suzuki, Zydus Life, and CONCOR …
Annual IG Wealth Management Retirement Study: Decline in Guaranteed Employer Pensions Leaving Many Canadians Underprepared for Retirement
According to IG Wealth Management’s (IG) annual retirement study, a major generational shift is re-shaping how Canadians approach retirement – and many are struggling
Tech Leads Stock Market Sell-Off as Jitters Flare Up on Wall Street
Key gauges of market sentiment turned sharply negative on Tuesday as software stocks slumped, deepening their losses since the start of the year.
Dow Jones And U.S. Index Outlook: Major Rotation Flows And Drops
Let’s dive into today’s session charts and key trading levels for the major US indices: the Dow Jones, Nasdaq, and S&P 500, as profit-taking
Stock market today: Nasdaq gets hit hardest as techs sink; Palantir climbs after earnings (live coverage)
Stock Market Today: Small caps join the S&P 500 and Dow in losses. Nvidia falls below this level.
Stock Market Today, Feb. 3: Novo Nordisk Slides as Pricing Pressure Clouds Obesity-Drug Outlook
Novo Nordisk dropped after management forecasts weaker 2026 growth, shifting attention from recent results to pricing pressure and rising competition in obesity treatments.